For the best viewing experience, make sure that you access MELODEM via this website (it should have “sites” in the URL):


November 16, 2023:  Dr. Carole Dufouil is an epidemiologist, biostatistician, and research director at the Bordeaux Population Health Inserm Center, as well as co-director of the VINTAGE team, and co-founder of the MELODEM Initiative.  Dr. Dufouil will present an update on the Memento Cohort and Data Access procedures.

Carole Dufouil

October 19th, 2023: Dr. Khadka will discuss quantile regressions as a tool to assess how the educational attainment-cognitive decline relationship varies along the cognition distribution and will also present an empirical example demonstrating these ideas in which he evaluates the effect of Vietnam-era G.I. Bill eligibility, a large-scale educational intervention in the US, on later-life, age-related memory decline.

Aayush Khadka

October 5th, 2023: Dr. Paloma Rojas-Saunero, a postdoctoral fellow at the Department of Epidemiology, Fielding School of Public health, UCLA will be presenting on “Effect of incident stroke on the risk of dementia over a period of 10 years of follow-up in a cohort of Asian American and white older adults in California.” Dr. Paloma Rojas-Saunera’s work focuses on how to extend the target trial framework and causal inference methods to study social determinants and cardiometabolic disorders in dementia and other aging related outcomes.

Paloma Rojas-Saunero

September 21st, 2023: Dr. Suzanne Judd, professor in the School of Public Health at the University of Alabama at Birmingham. Dr. Judd will be introducing us to two amazing cohort studies on which she is a PI: REGARDS and RURAL. Her research focuses on racial and regional differences in brain health with a particular focus on nutritional drivers of differences.

Suzanne Judd

May 4th, 2023: Elizabeth Rose Mayeda, University of California, Los Angeles, Fielding School of Public Health will be presenting on “How much does amyloid burden predict memory decline at the population level? A transportability analysis.”

Elizabeth Rose Mayeda (email for recording)

April 20th, 2023: Jennifer J. Manly, Department of Neurology and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University,  “Methods for Estimating National Prevalence of Dementia and MCI from the Harmonized Cognitive Assessment Protocol Project.”

Jennifer J. Manly

April 6th, 2023: Maude Wagner, BPH Research Center, Bordeaux University, “Using Longitudinal Continuous Measures to Capture Key Complementary Dimensions of Cognitive Resilience to AD Neuropathology”

Maude Wagner

March 16th, 2023: Roch A. Nianogo, Fielding School of Public Health, UCLA, “Risk Factors Associated with Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US”

Roch A. Nianogo

March 2nd, 2023: Lon S. Schneider, Keck School of Medicine of USC, “Lecanemab: effectiveness, approval, and why it takes a village”

Lon S. Schneider

February 16th, 2023: Terry M Therneau, Department of Quantitative Health Sciences, Mayo Clinic “Competing risks and the Fine-Gray model”

Terry Therneau

February 2nd, 2023: Erin E. Bennett, The George Washington University Milken Institute School of Public Health, “Methodological considerations in target trial emulation using cohort studies: estimating the effect of antihypertensive medication initiation on incident dementia in ARIC, CHS, and HRS”

Erin Bennett

January 19th, 2023: Marina Sirota, Bakar Computational Health Sciences Institute, UCSF, “Leveraging Molecular and Clinical Data to Better Understand Alzheimer’s Disease”

Marina Sirota


December 15th, 2022: Sepideh Modrek, San Francisco State University, Health Equity Institute & David Rehkopf, Stanford University, “Long-term effects of Local Area New Deal Work-Relief in Childhood on Educational and Cognitive Outcomes over the Life Course”

Sepideh Modrek & David Rehkopf

December 1, 2022: Tara E. Jenson, Zilber School of Public Health, University of Wisconsin – Milwaukee, “Environmental Cadmium Exposures, Cognitive Performance in Older Adults, and Subsequent Alzheimer’s Disease Mortality.”

Tara Jenson

November 3, 2022: Tianhao Wang, Rush Alzheimer’s Disease Center, Rush University Medical Center, “The ‘cognitive clock’: A novel indicator of brain health”

Tianhao Wang

October 20, 2022: Emma Nichols, Johns Hopkins Bloomberg School of Public Health, The use of algorithms for the identification of incident dementia: challenges and potential biases:

Emma Nichols

October 6, 2022: John (Rob) Warren, Minnesota Population Center, University of Minnesota “High School & Beyond: Turning an Education Cohort Study into an ADRD Study.”

Rob Warren

September 15, 2022: Marcia P Jimenez, Boston University &  L. Paloma Rojas-Saunero, UCLA “Racial and ethnic differences in the risk of dementia under hypothetical blood-pressure-lowering interventions: The Multi-Ethnic Study of Atherosclerosis.”

Marcia P Jimenez &  L. Paloma Rojas-Saunero


November 18, 2021: Madhav Thambisetty, NIA/NIH, “From Mechanisms to Medicines: realizing the DREAM of an Alzheimer’s cure.”


October 28, 2021: Venexia Walker, University of Bristol, Predicting drug repurposing opportunities for Alzheimer’s disease prevention using genome-wide association study data.”


October 7, 2021: Maria Glymour, UCSF, “Introduction to using Directed Acyclic Graphs to represent assumptions, guide analysis decisions, and argue with colleagues.”


July 15, 2021: Thomas Nedelec, Paris Brain Institute, “Data-driven identification of health conditions associated with incident Alzheimer’s disease dementia risk: a 15 years follow-up cohort from electronic health records in France and the United Kingdom.”


April 29, 2021: “Re-orienting to MELODEM”

Re-orienting to MELODEM

April 1, 2021: Zach Baucom, Boston University School of Public Health, “Using State Space Models for Longitudinal Neuropsychological Outcomes”

Zach Baucom

March 18, 2021: Lon Schneider, University of Southern California, “Methodological features & FDA’s regulatory guidance on aducanumab and Alzheimer drug development”

Lon Schneider

March 4, 2021: Terry Therneau, Mayo Clinic, “Multi-state survival models and dementia”

Terry Therneau

February 18, 2021: Andrew Stokes, Assistant Professor of Global Health, Boston University School of Public Health, “Estimations of the Association of Dementia with US Mortality Levels Using Linked Survey and Mortality Records”

Andrew Stokes

February 11, 2021: Julie Zissimopoulos, Price School of Public Policy and Schaeffer Center for Health Policy and Economics, University of Southern California, “Drug therapies for chronic conditions and risk of ADRD:  analyses using claims data”

Julie Zissimpoulos

February 4, 2021: Justina Avila-Rieger, Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Irving Medical Center, “Using Multilevel Analysis of Individual Heterogeneity & Discriminatory Accuracy (MAIHDA) to Examine Intersectional Inequalities in Cognitive Aging”

Justina Avila-Rieger


December 10, 2020: Maria Corrada, University of California, Irvine, & Sevil Yasar, Johns Hopkins University, “Statin Use, Hx of High Cholesterol & Risk of Dementia in the Oldest-old: illustration of challenges when analyzing pharmacoepidemiological data”

Maria Corrada & Sevil Yasar

December 3, 2020: Eric Tchetgen Tchetgen, Luddy Family President’s Distinguished Professor and Professor of Statistics, Department of Statistics, The Wharton School, The University of Pennsylvania, “MR GENIUS: A Principled Approach to Robust Mendelian Randomization Interference”

Eric Tchetgen Tchetgen

July 9, 2020: Bryan James, Rush Alzheimer’s Disease Center, Rush University Medical Center“Implications of covid for dementia researchers”

Bryan James